Legal & General Group plc: a top Footsie dividend stock for 2018

Interested in a 5.6% yield? Edward Sheldon explains why he rates Legal & General Group plc (LON: LGEN) as one of the best dividend stocks now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK dividend investors are a fortunate bunch as the FTSE 100 index is filled with high-yielding stocks. Indeed, almost a third of the stocks within it currently yield over 4%. Yet some dividend stocks are better than others. Many of the highest yielding companies right now, such as Royal Dutch Shell and GlaxoSmithKline, have struggled with profitability in recent years. That means we can’t rule out dividend cuts in the near term.

Today, I’m revealing one of my top dividend stock picks for 2018. It ticks all the boxes – a high yield, ample coverage, strong dividend growth and a low valuation. The stock I’m referring to is Legal & General Group (LSE: LGEN). Here’s why I’m bullish.

High dividend yield

Legal & General paid its shareholders 14.4p per share last year. At the current share price, that’s an excellent yield of 5.3%. According to Stockopedia, that made the insurer the 10th highest yielding stock in the FTSE 100.

Now the thing with high-yielding stocks is that sometimes you have to be careful. A strong yield can often signal that the company is in trouble, and that a dividend cut is on the cards. Yet in Legal & General’s case, this doesn’t look to be the case. Here’s why.

Dividend coverage

Investors often use the dividend coverage ratio to assess whether a company can afford to pay its dividend. This is calculated by dividing earnings by dividends. Ideally we want to see a ratio of around 2 times, but anything over 1.5 is generally fine. If the ratio is under 1.2, that’s when we should be concerned.

In Legal & General’s case, earnings last year were 22.2p per share. That gives a coverage ratio of 1.54, suggesting that the company could comfortably afford its distribution. 

Dividend growth

Another important indicator of dividend health is the growth of the payout. Turning back to Shell and Glaxo, neither company has increased its payout in recent years. That’s a warning sign.

But Legal & General has recorded seven consecutive dividend increases now and has boosted its payout by 55% over the last three years. That’s what you want as a dividend investor, as a rising dividend tends to put upwards pressure on the company’s share price.

Analysts expect 6% growth for FY2017, taking the estimated payout to 15.2p per share.

Valuation

Another reason I’m attracted to the stock is its low valuation. With analysts expecting earnings of 25.3p per share for the year just passed, the estimated P/E ratio is just 10.8. At a time when many FTSE 100 stocks are trading at lofty valuations, that valuation leaves a margin for error in my view.

Momentum

Lastly, the company has significant operational momentum at present, announcing in December that it is on track for a record year of earnings and profits. Management said that the group remains “strategically well placed to deliver strong, attractive growth and returns” in its core markets.

Weighing up all these factors, Legal & General’s dividend prospects look compelling. The stock is a ‘buy’ for me.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in Legal & General Group, Royal Dutch Shell and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Royal Dutch Shell B. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Up 12% today, here’s a great FTSE 250 growth share to consider!

Softcat's share price is soaring following a blockbuster first-half trading announcement. Here's why the FTSE 250 share is worth a…

Read more »

Growth Shares

Prediction: in 1 year, the easyJet share price could be as high as…

Jon Smith points out why the easyJet share price could head higher over the coming year based on the current…

Read more »

Investing Articles

Up 21% with dividends on top! See the stunning Shell share price forecast for 2025

Brokers are feeling optimistic about the outlook for the Shell share price, predicting solid growth this year. But Harvey Jones…

Read more »

Investing Articles

£10,000 invested in AstraZeneca shares 1 year ago is now worth…

AstraZeneca shares have recovered from their brief slump with investors broadly buoyed by the company’s long-term business prospects.

Read more »

Investing Articles

What’s going on with Nvidia stock?

Nvidia stock has slumped, and it seems that CEO Jensen Huang may have lost the Midas touch after his AI…

Read more »

Investing For Beginners

Starting at 46, how much would need to be invested in the FTSE 100 to have £445k by retirement?

Jon Smith provides a rundown of the strategy, specific ideas and the numbers involved to grow a FTSE 100 portfolio…

Read more »

Investing Articles

3 top AIM stocks to consider buying before they recover

AIM stocks aren't for faint-hearted investors. But here are three high-quality examples for the risk-tolerant to ponder buying while they're…

Read more »

Black father and two young daughters dancing at home
Investing Articles

The M&G share price soars 5% as it raises its dividend outlook despite £1.9bn in outflows

The M&G share price was given a boost this morning after its full-year results revealed a progressive dividend policy. Our…

Read more »